| scholarly article | Q13442814 |
| P2093 | author name string | Yuping Wang | |
| Jing Zheng | |||
| Yang Song | |||
| Jin-Young Chung | |||
| Ronald R Magness | |||
| P2860 | cites work | Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. | Q47996798 |
| Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. | Q52192148 | ||
| Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. | Q54021736 | ||
| VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. | Q54078205 | ||
| Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia | Q56619500 | ||
| Amniotic fluid–soluble vascular endothelial growth factor receptor-1 in preeclampsia | Q57382238 | ||
| Identification of an angiogenic mitogen selective for endocrine gland endothelium | Q59050729 | ||
| VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia | Q61484906 | ||
| Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia | Q73015047 | ||
| VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery | Q73414919 | ||
| The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases | Q73829721 | ||
| Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast | Q77145662 | ||
| Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor | Q24321564 | ||
| The biology of VEGF and its receptors | Q27860704 | ||
| Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected] | Q28140705 | ||
| Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 | Q28507115 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation | Q28592073 | ||
| Differential expression of VEGF isoforms in mouse during development and in the adult | Q28592341 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding | Q28646414 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells | Q30864177 | ||
| The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. | Q33301664 | ||
| Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes | Q33940345 | ||
| Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis | Q34019593 | ||
| Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
| The endocrinology of pre-eclampsia | Q34920656 | ||
| Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome | Q35750283 | ||
| Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189 | Q36636478 | ||
| EGR1 target genes in prostate carcinoma cells identified by microarray analysis. | Q38308423 | ||
| New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females | Q38989371 | ||
| A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration | Q40392328 | ||
| Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endot | Q40968932 | ||
| Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta | Q41385756 | ||
| Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells | Q42440033 | ||
| Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways | Q43606331 | ||
| The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency | Q44317160 | ||
| Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia | Q45084179 | ||
| Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes | Q46124194 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 2484-2490 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies | |
| P478 | volume | 89 |
| Q33877489 | A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth |
| Q37257615 | A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia |
| Q33725645 | Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies |
| Q57797508 | Adapting in vitro dual perfusion of the human placenta to soluble oxygen tensions associated with normal and pre-eclamptic pregnancy |
| Q37279565 | Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease |
| Q27000996 | An unexpected tail of VEGF and PlGF in pre-eclampsia |
| Q51953925 | Angiogenic growth factors and their receptors in first-trimester human decidua of pregnancies further complicated by preeclampsia or fetal growth restriction. |
| Q54328595 | Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia. |
| Q35756049 | Biochemical markers for prediction of preclampsia: review of the literature. |
| Q52054817 | Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy. |
| Q36605199 | Circulating lymphangiogenic factors in preeclampsia |
| Q90538941 | Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns |
| Q38747396 | Effect of Cytokines on the Formation Tube-Like Structures by Endothelial Cells in the Presence of Trophoblast Cells. |
| Q39181847 | Effects of placental secretory factors on cytokine production by endothelial cells |
| Q33826099 | Enhanced cellular responses and distinct gene profiles in human fetoplacental artery endothelial cells under chronic low oxygen |
| Q40357672 | Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells |
| Q37733724 | Expression of G-protein subunit α-14 is increased in human placentas from preeclamptic pregnancies. |
| Q34008266 | Expression of aryl hydrocarbon receptor in human placentas and fetal tissues |
| Q33736940 | Expression of placental growth factor mRNA in preeclampsia |
| Q34979389 | Gene expression analysis of VEGF and its receptors and assessment of its serum level in unexplained recurrent spontaneous abortion |
| Q35918271 | Human placental expression of SLIT/ROBO signaling cues: effects of preeclampsia and hypoxia |
| Q47685227 | ITE Suppresses Angiogenic Responses in Human Artery and Vein Endothelial Cells: Differential Roles of AhR. |
| Q35658124 | Impacts of Maternal Nutrition on Vascularity of Nutrient Transferring Tissues during Gestation and Lactation |
| Q36725906 | In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts. |
| Q51975690 | Molecular evidence of placental hypoxia in preeclampsia. |
| Q35655676 | Noninvasive detection of trophoblast protein signatures linked to early pregnancy loss using trophoblast retrieval and isolation from the cervix (TRIC). |
| Q34255152 | Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia |
| Q35893973 | Phosphorylation of Ser-279/282 and Tyr-265 positions on Cx43 as possible mediators of VEGF-165 inhibition of pregnancy-adapted Ca2+ burst function in ovine uterine artery endothelial cells |
| Q36067967 | Placental angiogenesis in sheep models of compromised pregnancy |
| Q36667589 | Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications |
| Q50947119 | Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies. |
| Q37278804 | Potential markers of preeclampsia--a review |
| Q36701614 | Potential roles of the prokineticins in reproduction |
| Q40040729 | Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function |
| Q35401872 | Preeclampsia does not alter vascular growth and expression of CD31 and vascular endothelial cadherin in human placentas |
| Q64074927 | Preeclampsia-Associated Alteration of DNA Methylation in Fetal Endothelial Progenitor Cells |
| Q34635145 | Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia |
| Q37222344 | Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta |
| Q39825445 | Role of EG-VEGF in human placentation: Physiological and pathological implications |
| Q35555933 | Role of nitric oxide in placental vascular development and function |
| Q90090385 | Status of VEGF in preeclampsia and its effect on endoplasmic reticulum stress in placental trophoblast cells |
| Q34733899 | The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development |
| Q26798193 | The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia |
| Q92515855 | The prediction of early preeclampsia: Results from a longitudinal proteomics study |
| Q34084917 | The role of VEGF-A165b in trophoblast survival. |
| Q34267491 | The vascular endothelial growth factor family in adverse pregnancy outcomes. |
| Q33581611 | Transcriptional and functional adaptations of human endothelial cells to physiological chronic low oxygen |
| Q90011558 | Vascular Endothelial Growth Factor Delivery to Placental Basal Plate Promotes Uterine Artery Remodeling in the Primate |
| Q37188408 | Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells |
| Q46251419 | Vascular endothelial growth factor receptor 1 (Flt1) and apoptosis in the preeclamptic placenta and effects of in vivo anti-hypertensive exposure. |
| Q90098532 | lncRNA TUG1 modulates proliferation, apoptosis, invasion, and angiogenesis via targeting miR-29b in trophoblast cells |
| Q35539017 | mRNA expression of VEGF and its receptors in fallopian tubes of women with ectopic pregnancies |
Search more.